Trial Profile
Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro in Patients With Hyperphosphataemia Undergoing Haemodialysis or Peritoneal Dialysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2019
Price :
$35
*
At a glance
- Drugs Sucroferric oxyhydroxide (Primary)
- Indications Hyperphosphataemia
- Focus Adverse reactions
- Acronyms VERIFIE
- Sponsors Vifor Fresenius Medical Care Renal Pharma
- 30 Sep 2019 Status changed from active, no longer recruiting to completed.
- 12 Oct 2018 Planned End Date changed from 1 Dec 2019 to 1 Apr 2019.
- 12 Oct 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Apr 2019.